News Conference News TCT 2024 Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI Michael O'Riordan November 06, 2024
News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
News Conference News TCT 2024 ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation Yael L. Maxwell October 29, 2024
News Conference News TCT 2024 More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact Yael L. Maxwell October 28, 2024
News Conference News TCT 2024 TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS Todd Neale October 28, 2024
News Conference News TCT 2024 EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis Michael O'Riordan October 28, 2024
News Conference News TCT 2024 EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS L.A. McKeown October 28, 2024
News Conference News TCT 2024 Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT Michael O'Riordan October 27, 2024
News Conference News EACTS 2024 TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb Yael L. Maxwell October 21, 2024
News Conference News ESC 2024 Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA Caitlin E. Cox September 04, 2024
News Conference News ESC 2024 NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD Michael O'Riordan September 01, 2024
News Conference News NY Valves 2024 Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR Todd Neale June 14, 2024
News Conference News NY Valves 2024 National Data Point to Soaring TAVI Rates in Patients Under 65 Michael O'Riordan June 14, 2024
News Conference News NY Valves 2024 Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis Todd Neale June 13, 2024
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Conference News NY Valves 2024 Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR Michael O'Riordan June 11, 2024
News Conference News NY Valves 2024 TEER May Be Option for Primary MR and ‘Red Zone’ Anatomy Todd Neale June 11, 2024
News Conference News NY Valves 2024 Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR Michael O'Riordan June 10, 2024
News Conference News NY Valves 2024 Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli Michael O'Riordan June 05, 2024